Advertisement

Myocardial Creep: we can now look it in the eye without framewise PET-CT registration for myocardial blood flow quantification

  • Elia von Felten
  • Andreas A. GiannopoulosEmail author
Editorial
  • 65 Downloads

It was Lance Gould, in early 1974, that first introduced the term “coronary flow reserve.”1 In an animal study including twelve dogs with surgically implanted electromagnetic flowmeter, resting flow and the flow after stress agent injection (remarkably contrast media; sodium diatrizoate) were compared. It was, for the first time, shown that in coronary stenoses, it is the stress flow that will decrease but not resting flow. The concept of a hemodynamic assessment of a stenosis was born and has since taken its position into medical history and clinical practice. Over the course of the years, nuclear imaging methods have further developed for the non-invasive assessment of the functional significance of coronary lesions. In 1984, a mathematical model was tested in vivo, for the first time, allowing calculation of the myocardial blood flow (MBF) in ml/g/min from positron emission tomography (PET) datasets in nine dogs using H 2 15 O as tracer.2 Since then, enormous technical progress has been made and MBF quantification using PET has found its way into clinical practice.3 Absolute MBF holds additional benefits over semiquantitative images alone as it allows advanced risk stratification, aids in the diagnosis and detection of balanced ischemia, and is decisive in the diagnosis of a microvascular disease.4, 5, 6

Nevertheless, calculation of absolute flow values in nuclear medicine techniques can be affected by patient-depending factors and technical issues, pitfalls, and artifacts.7 Among the most frequent artifacts is myocardial upward creep that was first described in myocardial single-photon emission computed tomography after physical exercise.8 In PET imaging, usually during vasodilator stress imaging, a reposition of the patient’s heart is observed due to alteration on the diaphragm–heart position, also potentially owing to the increase in lung volume with deeper and faster inspiration and expiration. The most essential consequence of this is that the misalignment of myocardial contours, primarily in the inferior and inferioseptal region, leading to false altered myocardial flow values, hampering the diagnostic accuracy of the test.9 Misalignment between PET and computer tomography (CT) attenuation images (AC) can also lead to biased MBF values.10 Myocardial creep could be in theory attributed on one hand on the misalignment of PET-CT AC and on the other hand on the myocardial contour position at the post-processing phase.

In the current issue of the Journal of Nuclear Cardiology, van Dijk et al. investigated the effect of framewise AC instead of single PET-CT AC on MBF in patients with myocardial creep.11 The authors retrospectively identified 31 patients (out of 64 consecutive patients) who underwent myocardial perfusion imaging using 82Rb-PET-CT, and in which myocardial creep was observed during regadenoson stress. The latter was defined as a misalignment of at least one-third of the width of the left ventricular myocardial contour in at least two frames. For the stress scans, two different approaches of co-registration with the CT images were tested prior to the reconstruction of the dynamic dataset with the CT-based AC. More specifically, a conventional late-time PET data alignment with the CT images and a semi-automated framewise attenuation correction approach for the early-time frames were investigated. The authors demonstrated a lower than 10% relative difference on the MBF between the two methods and there was no statistically significant difference on the total- and arterial territorial-specific MBF measurements between the two methods. Furthermore, the difference in MBF between the two reconstruction methods did not correlate with the shifting difference between the CT and PET images.

Misregistration between CT attenuation and emission PET images can be a common source of artifacts. In two hundred and fifty-nine consecutive patients who underwent 82Rb-PET, a misregistration of the myocardium of less than 6 mm was shown to result in less artifacts; a concept that was later also demonstrated for MBF quantification.10,12 In a simulation study with 82Rb- myocardial perfusion PET, a misregistration of 10 mm resulted in an overestimation of global MBF up to 9%. While in the latter study misregistration was present during the whole acquisition time, the fundamental difference is the temporal component as in the current real-life study by van Dijk et al., misregistration was observed in just about 25% of the frames (4.3 ± 1.1). Notably, although the 10% relative difference on the MBF was not shown to be significant, the sample size of the study is certainly small to assess the clinical relevance of the findings. Nevertheless, these results derived from real patient data could potentially be extrapolated into the general population, scanned with the specific protocol, PET-CT scanners, and vasodilators. Certainly, more clinical studies are warranted to confirm this assumption and to generalize the findings to other tracers and stress agents.

The authors deserve plenty of credit for addressing this essential technical issue on 82Rb-PET-derived MBF calculation, adding one more step towards perfecting MBF measurements. From our experience, although myocardial creep is commonly present in stress datasets, in a small number of patients it could also be seen during rest imaging; recognition and correction are needed in both stress and rest scans and for all pharmacological vasodilators. The less prone to artifact PET myocardial perfusion imaging is, the more accurate shall the results be, allowing us to better assess quantitatively the hemodynamics of coronary lesions and subsequently to enhance our understanding of the underlying pathophysiological mechanisms. Cardiovascular imagers should be aware and notice myocardial creep and software vendors must allow control to the operators in each processing and post-processing step that could influence the calculations of physiological parameters. It is of prime importance to work with accurate numbers that can be translated into clinical meaningful reports.

Notes

Disclosure

The University Hospital Zurich holds a research contract with GE Healthcare.

References

  1. 1.
    Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974;33:87-94.CrossRefGoogle Scholar
  2. 2.
    Bergmann SR, Fox KA, Rand AL, McElvany KD, Welch MJ, Markham J, et al. Quantification of regional myocardial blood flow in vivo with H215O. Circulation 1984;70:724-33.CrossRefGoogle Scholar
  3. 3.
    Moody JB, Lee BC, Corbett JR, Ficaro EP, Murthy VL. Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective. J Nucl Cardiol 2015;22:935-51.CrossRefGoogle Scholar
  4. 4.
    Camici PG, Rimoldi OE. The clinical value of myocardial blood flow measurement. J Nucl Med 2009;50:1076-87.CrossRefGoogle Scholar
  5. 5.
    Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography: Added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.CrossRefGoogle Scholar
  6. 6.
    Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI cardiovascular council and the ASNC. J Nucl Cardiol 2018;25:269-97.CrossRefGoogle Scholar
  7. 7.
    Klein R, Beanlands RSB, deKemp RA. Quantification of myocardial blood flow and flow reserve: Technical aspects. J Nucl Cardiol 2010;17:555-70.CrossRefGoogle Scholar
  8. 8.
    Friedman J, Train KV, Maddahi J, Rozanski A, Prigent F, Bietendorf J, et al. “Upward creep” of the heart: A frequent source of false-positive reversible defects during thallium-201 stress-redistribution SPECT. J Nucl Med 1989;30:1718-22.Google Scholar
  9. 9.
    Votaw JR, Packard RRS. Technical aspects of acquiring and measuring myocardial blood flow: Method, technique, and QA. J Nucl Cardiol 2018;25:665-70.CrossRefGoogle Scholar
  10. 10.
    Rajaram M, Tahari AK, Lee AH, Lodge MA, Tsui B, Nekolla S, et al. Cardiac PET/CT misregistration causes significant changes in estimated myocardial blood flow. J Nucl Med 2013;54:50-4.CrossRefGoogle Scholar
  11. 11.
    van Dijk JD, Jager PL, Ottervanger JP, Slump CH, van Dalen JA. No need for frame-wise attenuation correction in dynamic Rubidium-82 PET for myocardial blood flow quantification. J Nucl Cardiol 2019.  https://doi.org/10.1007/s12350-019-01654-7.Google Scholar
  12. 12.
    Gould KL, Pan T, Loghin C, Johnson NP, Guha A, Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: A definitive analysis of causes. Conseq Correct 2007;48:1112-21.Google Scholar

Copyright information

© American Society of Nuclear Cardiology 2019

Authors and Affiliations

  1. 1.Cardiac Imaging, Department of Nuclear MedicineUniversity Hospital ZurichZurichSwitzerland
  2. 2.Cardiology DepartmentUniversity Hospital ZurichZurichSwitzerland

Personalised recommendations